"Stanovisko v\u00FDboru \u010CSAT k doporu\u010Den\u00EDm ESC/EAS pro diagnostiku a l\u00E9\u010Dbu dyslipidemi\u00ED z roku 2011"@cs . "Bl\u00E1ha, Vladim\u00EDr" . . . . "Freiberger, Tom\u00E1\u0161" . "Vaverkov\u00E1, Helena" . "16" . "Kraml, Pavel" . . "diagnostics and treatment; dyslipidemia; guidelines"@en . . "RIV/00023001:_____/13:00058451" . . . "11"^^ . . "So\u0161ka, Vladim\u00EDr" . "C\u00EDfkov\u00E1, Renata" . "Opinion of the Czech Atherosclerosis Society's committee (CSAT) on the ESC/EAS guidelines related to the diagnostics and treatment of dyslipidemias issued in 2011"@en . . . . "1"^^ . "This position statement of the Executive Committee of the Czech Society for Atherosclerosis (CSAT) summarizes the most important aspects and novelties of the latest European guidelines for the management of dyslipidemia. In particular the position statement comments on: cardiovascular risk stratification, indications for plasma lipid and lipoprotein levels assessment as well as target lipid values, evaluation of current options for both lifestyle and pharmacological treatment of lipid metabolism disorders and, also, recommendation for laboratory monitoring of patients treated with lipid lowering agents. The statement deals with actual concepts of management of dyslipiemia in everyday practice, e.g. therapy of dyslipidemia in special patients' groups. This statement does not replace the latest guidelines but focuses on the changes from the former guidelines for dyslipidemia management, published by CSAT in 2007."@en . "CZ - \u010Cesk\u00E1 republika" . "Pi\u0165ha, Jan" . "Stanovisko v\u00FDboru \u010CSAT k doporu\u010Den\u00EDm ESC/EAS pro diagnostiku a l\u00E9\u010Dbu dyslipidemi\u00ED z roku 2011" . "Rosolov\u00E1, Hana" . . "6"^^ . . "Vrabl\u00EDk, Michal" . "Diabetologie Metabolismus Endokrinologie V\u00FD\u017Eiva" . . "107639" . "1211-9326" . "Toto stanovisko v\u00FDboru \u010Cesk\u00E9 spole\u010Dnosti pro ateroskler\u00F3zu (\u010CSAT) k posledn\u00EDm evropsk\u00FDm doporu\u010Den\u00EDm pro diagnostiku a l\u00E9\u010Dbu dyslipidemi\u00ED shrnuje nejd\u016Fle\u017Eit\u011Bj\u0161\u00ED aspekty a novinky v t\u00E9to problematice v n\u00E1sleduj\u00EDc\u00EDch oblastech: stratifikace kardiovaskul\u00E1rn\u00EDho rizika, indikace pro vy\u0161et\u0159en\u00ED s\u00E9rov\u00FDch lipid\u016F a lipoprotein\u016F a jejich c\u00EDlov\u00E9 hodnoty, rozbor mo\u017Enost\u00ED nefarmakologick\u00E9 i farmakologick\u00E9 l\u00E9\u010Dby poruch lipidov\u00E9ho metabolizmu a tak\u00E9 doporu\u010Den\u00ED pro laboratorn\u00ED monitorov\u00E1n\u00ED pacient\u016F, l\u00E9\u010Den\u00FDch hypolipidemiky. Stanovisko se vyjad\u0159uje i k aktu\u00E1ln\u00EDm ot\u00E1zk\u00E1m managementu dyslipidemi\u00ED v ka\u017Edodenn\u00ED praxi, nap\u0159. k l\u00E9\u010Db\u011B dyslipidemi\u00ED ve specifick\u00FDch skupin\u00E1ch pacient\u016F. Toto stanovisko nenahrazuje publikovan\u00E9 doporu\u010Den\u00E9 postupy, ale upozor\u0148uje na to, co se zm\u011Bnilo ve srovn\u00E1n\u00ED s p\u0159edch\u00E1zej\u00EDc\u00EDmi doporu\u010Den\u00EDmi \u010CSAT pro l\u00E9\u010Dbu dyslipidemi\u00ED z roku 2007."@cs . "I, V" . "Urbanov\u00E1, Zuzana" . "[7EE32AA27C24]" . "http://www.tigis.cz/images/stories/DMEV/2013/01/04_doporuceni_vrablik_dmev_1-13.pdf" . "Toto stanovisko v\u00FDboru \u010Cesk\u00E9 spole\u010Dnosti pro ateroskler\u00F3zu (\u010CSAT) k posledn\u00EDm evropsk\u00FDm doporu\u010Den\u00EDm pro diagnostiku a l\u00E9\u010Dbu dyslipidemi\u00ED shrnuje nejd\u016Fle\u017Eit\u011Bj\u0161\u00ED aspekty a novinky v t\u00E9to problematice v n\u00E1sleduj\u00EDc\u00EDch oblastech: stratifikace kardiovaskul\u00E1rn\u00EDho rizika, indikace pro vy\u0161et\u0159en\u00ED s\u00E9rov\u00FDch lipid\u016F a lipoprotein\u016F a jejich c\u00EDlov\u00E9 hodnoty, rozbor mo\u017Enost\u00ED nefarmakologick\u00E9 i farmakologick\u00E9 l\u00E9\u010Dby poruch lipidov\u00E9ho metabolizmu a tak\u00E9 doporu\u010Den\u00ED pro laboratorn\u00ED monitorov\u00E1n\u00ED pacient\u016F, l\u00E9\u010Den\u00FDch hypolipidemiky. Stanovisko se vyjad\u0159uje i k aktu\u00E1ln\u00EDm ot\u00E1zk\u00E1m managementu dyslipidemi\u00ED v ka\u017Edodenn\u00ED praxi, nap\u0159. k l\u00E9\u010Db\u011B dyslipidemi\u00ED ve specifick\u00FDch skupin\u00E1ch pacient\u016F. Toto stanovisko nenahrazuje publikovan\u00E9 doporu\u010Den\u00E9 postupy, ale upozor\u0148uje na to, co se zm\u011Bnilo ve srovn\u00E1n\u00ED s p\u0159edch\u00E1zej\u00EDc\u00EDmi doporu\u010Den\u00EDmi \u010CSAT pro l\u00E9\u010Dbu dyslipidemi\u00ED z roku 2007." . "\u0160tulc, Tom\u00E1\u0161" . . "RIV/00023001:_____/13:00058451!RIV14-MZ0-00023001" . "Stanovisko v\u00FDboru \u010CSAT k doporu\u010Den\u00EDm ESC/EAS pro diagnostiku a l\u00E9\u010Dbu dyslipidemi\u00ED z roku 2011" . . "Opinion of the Czech Atherosclerosis Society's committee (CSAT) on the ESC/EAS guidelines related to the diagnostics and treatment of dyslipidemias issued in 2011"@en . "11-12" . "Stanovisko v\u00FDboru \u010CSAT k doporu\u010Den\u00EDm ESC/EAS pro diagnostiku a l\u00E9\u010Dbu dyslipidemi\u00ED z roku 2011"@cs .